LIU Jin-yi, REN Li-wen, LI Sha, TANG Qin, LI Wan, ZHENG Xiang-jin, WANG Jin-hua, DU Guan-hua. Research progress of tumor immune and tumor metabolic drug targetsJ. Acta Pharmaceutica Sinica, 2019,54(10): 1718-1727. doi: 10.16438/j.0513-4870.2019-0581
Citation: LIU Jin-yi, REN Li-wen, LI Sha, TANG Qin, LI Wan, ZHENG Xiang-jin, WANG Jin-hua, DU Guan-hua. Research progress of tumor immune and tumor metabolic drug targetsJ. Acta Pharmaceutica Sinica, 2019,54(10): 1718-1727. doi: 10.16438/j.0513-4870.2019-0581

Research progress of tumor immune and tumor metabolic drug targets

  • The occurrence and development of tumors are closely related to the tumor microenvironment. Among them, tumor immune microenvironment and tumor metabolic microenvironment play important roles in tumor. Tumor immunotherapy is a way to kill tumor cells by activating the body's immune system. Tumor immuno-therapy has shown good therapeutic effects in a variety of solid tumors. In recent years, significant progress has been made in tumor immunotherapy. The Warburg effect indicates that tumor cells use aerobic glycolysis to acquire energy. In the tumor, the energy metabolism pathway is abnormal, and the tumor microenvironment can induce the reprogramming of tumor cell metabolism. Therefore, targeting tumor metabolism is also of great signifi-cance for tumor treatment. In this paper, we reviewed the research progress of drug targets related to tumor immu-nology and tumor metabolism in recent years, as well as the progress of drug development.
  • loading

Catalog

    Turn off MathJax
    Article Contents

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return